347 related articles for article (PubMed ID: 27867890)
1. Bone turnover markers: Emerging tool in the management of osteoporosis.
Shetty S; Kapoor N; Bondu JD; Thomas N; Paul TV
Indian J Endocrinol Metab; 2016; 20(6):846-852. PubMed ID: 27867890
[TBL] [Abstract][Full Text] [Related]
2. Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis.
Camacho PM; Lopez NA
Clin Chem Lab Med; 2008; 46(10):1345-57. PubMed ID: 18844486
[TBL] [Abstract][Full Text] [Related]
3. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
Vasikaran S; Eastell R; Bruyère O; Foldes AJ; Garnero P; Griesmacher A; McClung M; Morris HA; Silverman S; Trenti T; Wahl DA; Cooper C; Kanis JA;
Osteoporos Int; 2011 Feb; 22(2):391-420. PubMed ID: 21184054
[TBL] [Abstract][Full Text] [Related]
4. Assessment of baseline bone turnover marker levels and response to risedronate treatment: Data from a Japanese phase III trial.
Mawatari T; Ikemura S; Matsui G; Iguchi T; Mitsuyasu H; Kawahara S; Maehara M; Muraoka R; Iwamoto Y; Nakashima Y
Bone Rep; 2020 Jun; 12():100275. PubMed ID: 32462056
[TBL] [Abstract][Full Text] [Related]
5. Bone turnover markers and bone mineral density in healthy mother-daughter pairs from South India.
Shetty S; Kapoor N; Dian Bondu J; Antonisamy B; Thomas N; Paul TV
Clin Endocrinol (Oxf); 2016 Nov; 85(5):725-732. PubMed ID: 27497063
[TBL] [Abstract][Full Text] [Related]
6. Bone turnover markers: understanding their value in clinical trials and clinical practice.
Civitelli R; Armamento-Villareal R; Napoli N
Osteoporos Int; 2009 Jun; 20(6):843-51. PubMed ID: 19190842
[TBL] [Abstract][Full Text] [Related]
7. Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis.
Lorentzon M; Branco J; Brandi ML; Bruyère O; Chapurlat R; Cooper C; Cortet B; Diez-Perez A; Ferrari S; Gasparik A; Herrmann M; Jorgensen NR; Kanis J; Kaufman JM; Laslop A; Locquet M; Matijevic R; McCloskey E; Minisola S; Pikner R; Reginster JY; Rizzoli R; Szulc P; Vlaskovska M; Cavalier E
Adv Ther; 2019 Oct; 36(10):2811-2824. PubMed ID: 31440982
[TBL] [Abstract][Full Text] [Related]
8. Use of Bone Turnover Markers in Clinical Practice for the Management of Osteoporosis in Korea: From the Survey on the Prescription Pattern of Bone Turnover Markers.
Ahn SH; Park SY; Yoo JI; Chung YJ; Jeon YK; Yoon BH; Kim HY; Lee SH; Lee J; Hong S
J Bone Metab; 2019 Nov; 26(4):271-277. PubMed ID: 31832393
[TBL] [Abstract][Full Text] [Related]
9. Role of biochemical markers in the management of osteoporosis.
Henriksen K; Christiansen C; Karsdal MA
Climacteric; 2015; 18 Suppl 2():10-8. PubMed ID: 26507704
[TBL] [Abstract][Full Text] [Related]
10. Quantitative prediction of bone mineral density by using bone turnover markers in response to antiresorptive agents in postmenopausal osteoporosis: A model-based meta-analysis.
Wu J; Wang C; Li GF; Tang ET; Zheng Q
Br J Clin Pharmacol; 2021 Mar; 87(3):1175-1186. PubMed ID: 32692857
[TBL] [Abstract][Full Text] [Related]
11. Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density.
Naylor KE; Bradburn M; Paggiosi MA; Gossiel F; Peel NFA; McCloskey EV; Walsh JS; Eastell R
Osteoporos Int; 2018 Jun; 29(6):1407-1417. PubMed ID: 29525970
[TBL] [Abstract][Full Text] [Related]
12. The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis.
Vasikaran SD; Chubb SA
Endocrine; 2016 May; 52(2):222-5. PubMed ID: 26906711
[TBL] [Abstract][Full Text] [Related]
13. Bone turnover markers: use in osteoporosis.
Naylor K; Eastell R
Nat Rev Rheumatol; 2012 Jun; 8(7):379-89. PubMed ID: 22664836
[TBL] [Abstract][Full Text] [Related]
14. Discovery of potential biomarkers for osteoporosis using LC-MS/MS metabolomic methods.
Wang J; Yan D; Zhao A; Hou X; Zheng X; Chen P; Bao Y; Jia W; Hu C; Zhang ZL; Jia W
Osteoporos Int; 2019 Jul; 30(7):1491-1499. PubMed ID: 30778642
[TBL] [Abstract][Full Text] [Related]
15. Use of bone turnover markers in clinical practice.
Biver E
Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):468-73. PubMed ID: 23128576
[TBL] [Abstract][Full Text] [Related]
16. Reference intervals of biochemical bone turnover markers for Saudi Arabian women: a cross-sectional study.
Ardawi MS; Maimani AA; Bahksh TA; Rouzi AA; Qari MH; Raddadi RM
Bone; 2010 Oct; 47(4):804-14. PubMed ID: 20659600
[TBL] [Abstract][Full Text] [Related]
17. Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis.
Biver E; Chopin F; Coiffier G; Brentano TF; Bouvard B; Garnero P; Cortet B
Joint Bone Spine; 2012 Jan; 79(1):20-5. PubMed ID: 21724445
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis.
Naylor KE; McCloskey EV; Jacques RM; Peel NFA; Paggiosi MA; Gossiel F; Walsh JS; Eastell R
Osteoporos Int; 2019 Apr; 30(4):917-922. PubMed ID: 30613868
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring.
Garnero P
Mol Diagn Ther; 2008; 12(3):157-70. PubMed ID: 18510379
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
